297 related articles for article (PubMed ID: 22427111)
1. Henipavirus membrane fusion and viral entry.
Aguilar HC; Iorio RM
Curr Top Microbiol Immunol; 2012; 359():79-94. PubMed ID: 22427111
[TBL] [Abstract][Full Text] [Related]
2. Henipavirus receptor usage and tropism.
Pernet O; Wang YE; Lee B
Curr Top Microbiol Immunol; 2012; 359():59-78. PubMed ID: 22695915
[TBL] [Abstract][Full Text] [Related]
3. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.
Negrete OA; Chu D; Aguilar HC; Lee B
J Virol; 2007 Oct; 81(19):10804-14. PubMed ID: 17652392
[TBL] [Abstract][Full Text] [Related]
4. Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head Domain.
Yeo YY; Buchholz DW; Gamble A; Jager M; Aguilar HC
J Virol; 2021 Sep; 95(20):e0066621. PubMed ID: 34288734
[TBL] [Abstract][Full Text] [Related]
5. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.
Sawatsky B; Grolla A; Kuzenko N; Weingartl H; Czub M
J Gen Virol; 2007 Feb; 88(Pt 2):582-591. PubMed ID: 17251577
[TBL] [Abstract][Full Text] [Related]
7. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus.
Negrete OA; Wolf MC; Aguilar HC; Enterlein S; Wang W; Mühlberger E; Su SV; Bertolotti-Ciarlet A; Flick R; Lee B
PLoS Pathog; 2006 Feb; 2(2):e7. PubMed ID: 16477309
[TBL] [Abstract][Full Text] [Related]
8. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors.
Xu K; Broder CC; Nikolov DB
Semin Cell Dev Biol; 2012 Feb; 23(1):116-23. PubMed ID: 22227101
[TBL] [Abstract][Full Text] [Related]
9. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
[TBL] [Abstract][Full Text] [Related]
10. Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.
Oguntuyo KY; Haas GD; Azarm KD; Stevens CS; Brambilla L; Kowdle SS; Avanzato VA; Pryce R; Freiberg AN; Bowden TA; Lee B
J Virol; 2024 Mar; 98(3):e0183823. PubMed ID: 38426726
[TBL] [Abstract][Full Text] [Related]
11. Envelope-receptor interactions in Nipah virus pathobiology.
Lee B
Ann N Y Acad Sci; 2007 Apr; 1102(1):51-65. PubMed ID: 17470911
[TBL] [Abstract][Full Text] [Related]
12. Novel Roles of the N1 Loop and N4 Alpha-Helical Region of the Nipah Virus Fusion Glycoprotein in Modulating Early and Late Steps of the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; Aguilar HC
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568505
[TBL] [Abstract][Full Text] [Related]
13. Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3.
Xu K; Rajashankar KR; Chan YP; Himanen JP; Broder CC; Nikolov DB
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9953-8. PubMed ID: 18632560
[TBL] [Abstract][Full Text] [Related]
14. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
15. Prefusion stabilization of the Hendra and Langya virus F proteins.
Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
[TBL] [Abstract][Full Text] [Related]
16. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics.
Steffen DL; Xu K; Nikolov DB; Broder CC
Viruses; 2012 Feb; 4(2):280-308. PubMed ID: 22470837
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus.
Lee B; Pernet O; Ahmed AA; Zeltina A; Beaty SM; Bowden TA
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2156-65. PubMed ID: 25825759
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate-dependent enhancement of henipavirus infection.
Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the G-H loop region of ephrin-B2 can enhance Nipah virus binding and infection.
Yuan J; Marsh G; Khetawat D; Broder CC; Wang LF; Shi Z
J Gen Virol; 2011 Sep; 92(Pt 9):2142-2152. PubMed ID: 21632558
[TBL] [Abstract][Full Text] [Related]
20. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
